SABCS: Addition of Tucatinib Ups Survival in HER2 + Metastatic Breast Cancer

In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression - free survival
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Neurology, Oncology, Pharmacy, Conference News, Source Type: news